 |
 |
|
|
|
RESÚMENES JULIO 2010 |
Antipsicóticos
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3! - Comparison of the effectiveness of depot
antipsychotics in routine clinical practice
Polash Shajahan, Elizabeth
Spence, Mark Taylor, Darlington Daniel, Anthony
Pelosi
The Psychiatrist (2010) 34: 273-279
3! - Assessment of adverse effects in clinical studies of
antipsychotic medication: survey of methods used
Alison Pope, Clive Adams,
Carol Paton, Tim Weaver, Thomas R. E. Barnes
The British Journal of Psychiatry (2010) 197: 67-72
3 - Management of antipsychotic-related
weight gain
Lawrence Maayan and
Christoph U Correll
Expert Review of Neurotherapeutics. July 2010, Vol. 10, No. 7,
Pages 1175-1200
3 - Evaluation of antioxidant
enzymes activities and lipid peroxidation in schizophrenic patients treated
with typical and atypical antipsychotics
Manuela Padurariu, Alin Ciobica, Irina Dobrin
and Cristinel Stefanescu
Neuroscience
Letters. Volume
479, Issue 3, 2 August 2010, Pages 317-320
3 - From receptor pharmacology
to improved outcomes: individualising the selection, dosing, and switching of
antipsychotics
C.U. Correll
European
Psychiatry. Volume
25, Supplement 2, June 2010, Pages S12-S21
4! - Relapse Prevention in
First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With
Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial
Within the German Research Network on Schizophrenia
Wolfgang Gaebel, Mathias Riesbeck; Wolfgang
Wölwer, Ansgar Klimke, Matthias Eickhoff, Martina von Wilmsdorff, Matthias
Lemke, Isabella Heuser, Wolfgang Maier, Wolfgang Huff, Andrea Schmitt, Heinrich
Sauer, Michael Riedel, Stefan Klingberg, Wolfgang Köpcke, Christian Ohmann, and
Hans-Jürgen Möller, for the German Study Group on First-Episode Schizophrenia
3! - Quality
of life and subjective well-being in schizophrenia and schizophrenia spectrum
disorders: Valid predictors of symptomatic response and remission?
Rebecca Schennach-Wolff, Markus
Jäger, Michael Obermeier, Max Schmauss, Gerd Laux, Herbert Pfeiffer, Dieter
Naber, Lutz G. Schmidt, Wolfgang Gaebel, Joachim Klosterkötter, Isabella
Heuser, Kai-Uwe Kühn, Matthias R. Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Florian Seemüller,
Hans-Jürgen Möller & Michael Riedel
World
Journal of Biological Psychiatry. August 2010, Vol. 11, No. 5
, Pages 729-738
5 - Topiramate augmentation of clozapine in schizophrenia: a double-blind,
placebo-controlled study
MRA Muscatello, A Bruno, G Pandolfo, U Micň, PM Bellinghieri,
G Scimeca, M Cacciola, D Campolo, S Settineri, R Zoccali
J of Psychopharmacology. July 8, 2010
3! - A 52-week open-label study of the safety and tolerability of paliperidone
palmitate in patients with schizophrenia
S Gopal, U
Vijapurkar, P Lim, M Morozova,
M Eerdekens, D Hough
GRATIS 3 - Emerging role of sertindole in the
management of schizophrenia
Stephanie L Cincotta, Joshua S Rodefer
Neuropsychiatric Disease and
Treatment. 2010;6:429 - 441
3 - Genetic
association of the GDNF alpha-receptor genes with schizophrenia and clozapine
response
Renan P. Souza, Marco A. Romano-Silva, Jeffrey
A. Lieberman, Herbert Y. Meltzer, Lesley T. MacNeil, Joseph G. Culotti, James
L. Kennedy and Albert H.C. Wong
Journal of Psychiatric Research. Volume 44, Issue 11,
August 2010, Pages 700-706
3 - Risperidone Overdose Causes Extrapyramidal Effects
But Not Cardiac Toxicity
Page, Colin B; Calver, Leonie A; Isbister, Geoffrey K
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 387-390
3! - Amisulpride Overdose Is Frequently Associated With QT
Prolongation and Torsades de Pointes
Isbister, Geoffrey K; Balit, Corrine R; Macleod, Dawson; Duffull,
Stephen B
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 391-395
4 - A Post Hoc Analysis of Negative Symptoms and
Psychosocial Function in Patients With Schizophrenia: A 40-Week Randomized,
Double-Blind Study of Ziprasidone Versus Haloperidol Followed by a 3-Year
Double-Blind Extension Trial
Stahl, Stephen M; Malla, Ashok; Newcomer, John W; Potkin, Steven G;
Weiden, Peter J; Harvey, Philip D; Loebel, Antony; Watsky, Eric; Siu, Cynthia O;
Romano, Steve
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 425-430
3! - Clozapine and Global Cognition in Schizophrenia
Rajji, Tarek K; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo,
David C; Remington, Gary; Pollock, Bruce G; Mulsant, Benoit H
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 431-436
3 - Augmentation With Pregabalin in Schizophrenia
Englisch, Susanne; Eer, Andrea; Enning, Frank; Hohmann, Sarah; Schanz,
Heike; Zink, Mathias
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 437-440
3 - Endocannabinoid Pro129Thr FAAH Functional
Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With
Antipsychotic-Induced Weight Gain
Monteleone,
Palmiero; Milano, Walter; Petrella, Claudio; Canestrelli, Benedetta; Maj, Mario
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 441-445
3 - Treatment Response Trajectories and Their Antecedents
in Recent-Onset Psychosis: A 2-Year Prospective Study
Levine, Stephen Z; Rabinowitz, Jonathan; Case, Michael; Ascher-Svanum,
Haya
Journal of Clinical Psychopharmacology: August 2010 -
Volume 30 - Issue 4 - pp 446-449
3 - Reboxetine Enhances the Olanzapine-Induced
Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated
Transmission
Monica M Marcus, Kent Jardemark, Anna Malmerfelt,
Carl Björkholm and Torgny H Svensson
Neuropsychopharmacology (2010) 35, 1952–1961
3! - Antipsychotics Associated with the Development of
Type 2 Diabetes in Antipsychotic-Naďve Schizophrenia Patients
Jimmi Nielsen, Sřren Skadhede and Christoph U Correll
Neuropsychopharmacology (2010) 35, 1997–2004
3 - Extrapyramidal
side-effects and dopamine D2/3 receptor binding in substantia nigra
Heli Tuppurainen, Jyrki T. Kuikka, Heimo Viinamäki, Minna Husso, Jari
Tiihonen
Nordic
Journal of Psychiatry. August 2010, Vol. 64, No. 4 , Pages 233-238
3 - Serum concentrations of paliperidone
versus risperidone and clinical effects
Yasmin
Nazirizadeh, Friederike Vogel, Wolfgang Bader, Ekkehard Haen, Bruno Pfuhlmann, Gerhard
Gründer, Michael Paulzen, Markus Schwarz, Gerald Zernig and Christoph Hiemke
European Journal of Clinical Pharmacology. Volume 66,
Number 8,
797-803
3 - Cannabis
use in patients with a first psychotic episode and subjects at ultra high risk
of psychosis: impact on psychotic- and pre-psychotic symptoms
Marise Machielsen, Suzanne van der Sluis & Lieuwe de Haan
Australian
and New Zealand Journal of Psychiatry. August 2010, Vol. 44, No. 8
, Pages 721-728
3 - Plasma Clozapine, Norclozapine, and the
Clozapine:Norclozapine Ratio in Relation to Prescribed Dose and Other Factors:
Data From a Therapeutic Drug Monitoring Service, 1993-2007
Couchman, Lewis; Morgan, Phillip Edgar; Spencer, Edgar Pathrose; Flanagan,
Robert James
Therapeutic Drug Monitoring: August 2010 - Volume 32 -
Issue 4 - pp 438-447
3 - Antipsychotic drug-induced
increases in ventral tegmental area dopamine neuron population activity via
activation of the nucleus accumbens–ventral pallidum pathway
Ornella Valenti and Anthony A. Grace
The International Journal of Neuropsychopharmacology
(2010), 13:845-860
3! - Adjunctive α2-adrenoceptor
blockade enhances the antipsychotic-like effect of risperidone and facilitates
cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission
Monica M. Marcus, Charlotte Wiker, Olivia Frĺnberg, Ĺsa
Konradsson-Geuken, Xavier Langlois, Kent Jardemark and Torgny H. Svensson
The International Journal of Neuropsychopharmacology
(2010), 13:891-903
3 - Dopamine D2/3
receptor occupancy by quetiapine in striatal and extrastriatal areas
Ingo Vernaleken, Hildegard Janouschek, Mardjan Raptis, Sandra Hellmann, Tanja
Veselinovic, Anno Bröcheler, Christian Boy, Paul Cumming, Christoph Hiemke, Frank
Rösch, Wolfgang M. Schäfer and Gerhard Gründer
The International Journal of Neuropsychopharmacology
(2010), 13:951-960
5 - A Double-Blind, Randomized
Study Comparing the Efficacy and Safety of Sertindole and Risperidone in
Patients With Treatment-Resistant Schizophrenia
John M. Kane, Steven G. Potkin, David G.
Daniel, and Peter F. Buckley
5 - Augmentation With
Citalopram for Suicidal Ideation in Middle-Aged and Older Outpatients With
Schizophrenia and Schizoaffective Disorder Who Have Subthreshold Depressive
Symptoms: A Randomized Controlled Trial
Sidney Zisook, John W. Kasckow, Nicole M.
Lanouette, Shahrokh Golshan, Ian Fellows, Ipsit Vahia, Somaia Mohamed, and
Sanjai Rao
J Clin Psychiatry 2010;71(7):915–922
3 - Does dopamine
mediate the psychosis-inducing effects of cannabis? A review and integration of
findings across disciplines
Rebecca Kuepper, Paul D.
Morrison, Jim van Os, Robin M. Murray, Gunter Kenis and Cécile Henquet
Schizophrenia
Research. Volume
121, Issues 1-3, August 2010, Pages 107-117
5< - Celecoxib
treatment in an early stage of schizophrenia: Results of a randomized,
double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride
treatment
Norbert Müller, Daniela Krause, Sandra Dehning,
Richard Musil, Rebecca Schennach-Wolff, Michael Obermeier, Hans-Jürgen Möller,
Volker Klauss, Markus J. Schwarz and Michael Riedel
Schizophrenia
Research. Volume
121, Issues 1-3, August 2010, Pages 118-124
3! - High dose D-serine
in the treatment of schizophrenia
Joshua T. Kantrowitz, Anil K. Malhotra,
Barbara Cornblatt, Gail Silipo, Andrea Balla, Raymond F. Suckow, Cyril D'Souza,
John Saksa, Scott W. Woods and Daniel C. Javitt
Schizophrenia
Research. Volume
121, Issues 1-3, August 2010, Pages 125-130
3 - Possible effects of some antipsychotic drugs on
C-reactive protein in a drug-naďve psychotic sample
Francisco J. Diaz, Rocío Pérez-Iglesias, Ignacio Mata,
Obdulia Martínez-Garcia, José L. Vázquez-Barquero, Jose de Leon and Benedicto
Crespo-Facorro
Schizophrenia
Research. Volume
121, Issues 1-3, August 2010, Pages 207-212
5< - Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine
administration and response to the antidiabetic metformin
Erika Fernández, Edgardo Carrizo, Virginia
Fernández, Lisette Connell, Ignacio Sandia, Dexy Prieto, Johana Mogollón,
Dennys Valbuena, Iliana Fernández, Enma Araujo de Baptista and Trino Baptista
Schizophrenia
Research. Volume
121, Issues 1-3, August 2010, Pages 213-217
3 - The time-dependent change of
insulin secretion in schizophrenic patients treated with olanzapine
Chih-Chiang Chiu, Chun-Hsin Chen, Bo-Yu Chen,
Shu-Han Yu and Mong-Liang Lu
3 - Role of cortical and striatal
5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal
disorders
Saki Shimizu, Ayaka Tatara, Junta Imaki and
Yukihiro Ohno
3 - Changes in heart rate dynamics
of patients with schizophrenia treated with risperidone
Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi,
Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim and
Yong Min Ahn
3 - A parametric
study of the acute effects of antipsychotic drugs on glucose sensitivity in an
animal model
Heidi N. Boyda, Lurdes Tse, Ric M. Procyshyn,
Daniel Wong, Tony K.Y. Wu, Cathy C. Pang and Alasdair M. Barr
3 - Switching from conventional
antipsychotics to ziprasidone: A randomized, open-label comparison of regimen
strategies
Emmanuel Stip, Simon Zhornitsky, Stéphane
Potvin and Valerie Tourjman
3 - Effects of olanzapine on brain-derived neurotrophic
factor gene promoter activity in SH-SY5Y neuroblastoma cells
Jung Goo Lee, Hye Yeon Cho,
Sung Woo Park, Mi Kyoung Seo and Young Hoon Kim
5 - Efficacy and Tolerability of Blonanserin in the
Patients With Schizophrenia: A Randomized, Double-blind, Risperidone-Compared
Trial
Yang, Jaewon; Bahk, Won-Myong; Cho, Hyun-Sang; Jeon, Yang-Whan; Jon,
Duk-In; Jung, Hee-Yeon; Kim, Chan-Hyung; Kim, Hee-Cheol; Kim, Yong-Ku; Kim,
Young-Hoon; Kwon, Jun-Soo; Lee, Sang-Yeol; Lee, Seung-Hwan; Yi, Jung-Seo; Yoon,
Bo-Hyun; Kim, Seung-Hyun
Clinical Neuropharmacology: July 2010 - Volume 33 -
Issue 4 - pp 169-175
3 - Salivary Flow Rate in Patients With Schizophrenia on
Clozapine
Praharaj, Samir Kumar; Jana, Amlan Kusum; Goswami, Kausik; Das, Poonam R;
Goyal, Nishant; Sinha, Vinod Kumar
Clinical Neuropharmacology: July 2010 - Volume 33 -
Issue 4 - pp 176-178
| Regresar a RESÚMENES JULIO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |